| 1992年 | 1993年 | 1994年 | 1995年 |
| 1996年 | 1997年 | 1998年 | 1999年 |
| 2000年 | 2001年 | 2002年 | 2003年 |
| 2004年 | 2005年 | 2006年 | 2007年 |
| 2008年 | 2009年 | 2010年 |
Endoh M, Yamashina M, Ohi H, Funabashi K, Ikuno T, Yasugi T, Atkinson JP, and Okada H.
Immunohistochemical demonstration of membrane cofactor protein (MCP) of complement in normal and diseased kidney tissues.
Clin Exp Immunol 1993 Oct;94(1):182-8
Funabashi K, Okada N, Matsuo S, Morgan BP, and Okada H.
Tissue distribution of complement regulatory membrane proteins in rats.
Immunology 1994 Mar;81(3):444-51
Yamada T, Hosokawa M, Satoh T, Moroo I, Takahashi M, Akatsu H, and Yamamoto T.
Immunohistochemistry with an antibody to human liver carboxylesterase in human brain tissue.
Brain Res 1994 Sep 26;658(1-2):163-7
Baranyi L, Okada N, Baranji K, Takizawa H, and Okada H.
Membrane bound complement regulatory activiy is decreased on vaccinia virus infected cells.
Clin Exp Immunol 1994 Oct;98(1):134-9
Baranyi L, Baranji K, Yoshida T, Okada N, and Okada H.
Partial characterization of a low molecular weight phagocytosis inhibitory factor obtained from human erythrocyte membranes.
Immunobiology 1994 Dec;192(1-2):94-105
Baranyi L, Del Carpio C, Campbell W, and Okada H.
Design of antisense peptides using evolutionary algorithm.
Congress Abstract of Japanese Society of Chemistry, p.326, Tokyo 1994
赤津裕康、岡田秀親
自己免疫疾患とアポトーシス（総論）
最新医学・第４９巻・第６号；1124-1130（1994）
中島捷久、信澤枝里、岡田秀親、中島節子、高橋三津雄、山田達夫
インフルエンザＡウイルスの神経病原性
日本臨床免疫学会会誌（1994, 17-6:772-775）
Yamada T, Yoshiyama Y, Sato H, Seiki M, Shinagawa A, and Takahashi M.
White matter microglia produce membrane -type matrix metalloprotease, an activater of gelatinase A, in human brain tissue.
Acta Neuropathol (Berl) 1995;90(5):421-4
Takahashi M, Yamada T, Nakajima S, Nakajima K, Yamamoto T,and Okada H.
The substantia nigra is a major target for neurovirulent influenza A virus.
J Exp Med 1995 Jun 1;181(6):2161-9
Wu X, Akatsu H, and Okada H.
Apoptosis of HIV-infected cells following treatment with Sho-saiko-to and its components.
Jpn J Med Sci Biol 1995 Apr;48(2):79-87
Higuchi K, Aoki K, Kimbara T, Hosoi N, Yamamoto T, and Okada H.
Suppression of natural killer cell activity by monocytes following immunotherapy for recurrent spontanous aborters.
Am J Reprod Immunol 1995 Mar;33(3):221-7
Jaossy T, Baranyi L, Vizler Cs, Nyirai I, and Veh P.
Induction of neonatal transplantation tolerance and lymphoprolypherative disorders in mice:The role of F1 donor cells.
Transplant Proc 1995 Feb;27(1):188-90
Baranyi L, Campbell W, Ohshima K, Fujimoto S, Boros M, and Okada H.
The antisense homology box: a new motive in proteins that often codes biologically active peptides.
Nat Med 1995 Sep;1(9):894-901
Yamada T, Miyazaki K, Koshikawa N, Takahashi M, Akatsu H,and Yamamoto T.
Selective localization of gelatinase A, an enzyme degrading b-amyloid protein, in white matter microglia and in Schwann cells.
Acta Neuropathol (Berl) 1995;89(3):199-203
Ojika K, Katada E, Tohdoh N, Mitake S, Otsuka Y, Matsukawa N, and Tsugu Y.
Demonstration of deacetyiated hippocampal cholinergic neurostimulating peptide and its protein in rat tissue.
Brain Res 1995 Dec 1;701(1-2):19-27
Mitake S, Ojika K, Katada E, Otsuka Y, Matsukawa N, and Fujimori O.
Accumulation of hippocampal cholinergic neurostimulating peptide(HCNP)-related componennts in Hirano bodies.
Neuropathol Appl Neurobiol 1995 Feb;21(1):35-40
Fukuoka Y, Yasui A, Okada N, and Okada H.
Molecular cloning of murine decay accelerating factor (DAF) by immunoscreening.
Int Immunol 1996 Mar;8(3):379-85
Takahashi M, Yamada T, Tooyama I, Moroo I, Kimura H, Yamamoto T, and Okada H.
Insulin receptor mRNA in the substantia nigra in Parkinson's disease.
Neurosci Lett 1996 Feb 9;204(3):201-4
Baranyi L, Campbell W, and Okada H.
Antisense homology boxes in C5a receptor and C5a anaphylatoxin. A new method for identification of potentially active peptides.
J Immunol 1996 Nov 15;157(10):4591-601
Akatsu H, Yamada T, Okada N, Yamamoto T, Yamashina M, and Okada H.
HRF20(CD59) expresses in Human Nervous Tissue.
Mol. Immunology, Abstr., 33, p45. (1996)
Akatsu H, Vanmechelen E, Ongena L, Yamamoto T, Yamada T, and Okada H.
Characterization of Tau in Cerebrospinal Fluids (CSF) of Neuropathological Confirmed Alzheimer cases.
Neurobiol. Aging, Abstr., 17, p166, 1996
Katada E, Mitake S, Matsukawa N, Otsuka Y, Tsugu Y, Fujmori O, and Ojika K.
Distribution of hippocampal cholinergic neurostimulating peptide (HCNP)-like immunoreactivity in organs and tissues of young Wistar rats.
Histochem Cell Biol 1996 Jan;105(1):43-51
Mitake S, Katada E, Otsuka Y, Matsukawa N, Iwase T, Tsugu Y, Fujimori O, and Ojika K.
Possible implication of hippocampal cholinergic neurostimulating peptide (HCNP)-related components i Hirano body formation.
Neuropathol Appl Neurobiol 1996 Oct;22(5):440-5
Mitake S, Ojika K, Katada E, Otsuka Y, Matsukawa N, and Fujimori O.
Distribution of hippocampal cholinerggic neurostimulating peptide (HCNP) immunoreactivity in the central nervous system of the rat.
Brain Res 1996 Jan 8;706(1):57-70
Akatsu H, Yamada T, Okada N, Yamamoto T, Yamashina M, and Okada H.
Unique expression of HRF20 (CD59) in human nervous tissue.
Microbiol Immunol 1997;41(4):321-9
Takahashi M, Yamada T, Nakanishi K, Fujita K, Nakajima K, Nobusawa E, Yamamoto T, Kato T, and Okada H.
Influenza A virus infection of primary cultured cells from rat fetal brain.
Parkinsonism & Related Disorders, 3: 97-102 (1997)
Akatsu H, Miwa T, Sakurade C, Fukuoka Y, Ember JA, Yamamoto T, Hugli TE, and Okada H.
cDNA cloning and characterization of rat C5a anaphylatoxin receptor.
Microbiol Immunol 1997;41(7):575-80
Kanie J, Kono K, Yamamoto T, Akatsu H, and Iguchi A.
[Gastro-esophageal reflux successfully treated with transgastrostomal jejunal tubefeeding].
Nippon Ronen Igakkai Zasshi 1997 Jan;34(1):60-4
蟹江治郎、河野和彦、山本孝之、赤津裕康、井口昭久
胃食道逆流のある高齢者に対しTGJ tube（Transe Gastrostomal Jejunal tube：経胃瘻的空腸栄養ﾁｭｰﾌﾞ）を用いた経管栄養管理により在宅管理が可能になった1例
日本老年医学会誌 第34巻第１号 p.60-64 1997/01
Tsuboi Y, Takahashi M, Ishikawa Y, Okada H, and Yamada T.
Elevated bradykinin and decreased carboxypeptidase R as a cause of hypotension during tryptophan column immunoabsorption therapy.
Ther Apher. 1998 Nov;2(4):297-9.
Farkas I, Baranyi L, Takahashi M, Fukuda A, Liposits Z, Yamamoto T, and Okada H.
Neuronal C5a receptor and an associated apoptotic signal transduction pathway.
J Physiol 1998 Mar 15;507 ( Pt 3):679-87
Boros M, Massberg S, Baranyi L, Okada H, and Messmer K.
Endothelin 1 induces leukocyte adhesion in submucosal venules of the rat small intestine.
Gastroenterology 1998 Jan;114(1):103-14
Baranyi L, Campbell W, Ohshima K, Fujimoto S, Boros M, Kaszaki J, and Okada H.
Antisense homology box derived peptides represent a new class of endothelin receptor inhibitors.
Peptides 1998;19(2):211-23
Watanabe M, Ishikawa Y, Campbell W, and Okada H.
Measurement of arginine carboxypeptidase-generating activity of adult plasma.
Microbiol Immunol 1998;42(5):393-7
Farkas E, Baranyi L, Takahashi M, Fukada A, Liposits Zs, Yamamoto T, Okada H.
C5a anaphylatoxin fragment causes apoptosis in TGW neuroblastoma cells.
Neuroscience 1998 Oct;86(3):903-11
Kanie J, Kono K, Yamamoto T, Akatsu H, Shimokata H, and Iguchi A.
Usefulness and problems of percutaneous endoscopic gastrostomy in a geriatric hospital
Nippon Ronen Igakkai Zasshi 1998 Jul;35(7):543-7
Kanie J, Shimokata H, Akatsu H, Yamamoto T, Iguchi A.
Complications Following Percutaneous Endoscopic Gastrostmy: Acute Respiratory Infection and Local Skin Infection.
Dig. Endsc.;10:205-210.(1998)
Baranyi L, Ohshima K, Fujimoto S, Kaszaki J, Campbell W, Boros M, Okada N, and Okada H.
Antisense homology Box derived peptides represent a new class of Endothelin receptor inhibitors.
Peptides 1998;19(2):211-23
Farkas I, Baranji L, Takahashi M, Fukuda A, Yamamoto T, and Okada H.
Neuronal C5a receptor and an associated apoptotic signal transduction pathway.
J Physiol 1998 Mar 15;507 ( Pt 3):679-87
蟹江治郎、河野和彦，山本孝之、赤津裕康，下方浩史，井口昭久
老人病院における経皮内視鏡的胃瘻造設術の問題と有用性
日本老年医学会誌 1998; 35(7): 543-547 1998/07
Kanie J, Shimokata H, Akatsu H, Yamamoto T, Iguchi A
Risk Factors for Complication Following Percutaneous Endoscopic Gastrostomy: Acute Respiratory Infection and Local Skin Infection
Digestive Endoscopy 1998; 10(3): 205-210 1998/07
Takahashi M, Akatsu H, Tsujioka Y, Yamamoto T, Tsuboi Y, Yamada T, Okada H
Detection of Borna Disease Virus Antigen and RNA in human autopsy brain samples from patients with dementia
NEUROBIOLOGY OF AGING 1998; 19(S),abstract:1137
Akatsu H, E.Vanmechelen, L.Ongena, Yamamoto T, Okada H
Increase of CSF tau levels in clinically and neuropathologically diagnosed Alzheimer cases
NEUROBIOLOGY OF AGING 1998; 19(S),abstract:690
Kanie J, Akatsu H, Yamamoto T, Shimokata H, Iguchi A
Experience of percutaneous endoscopic gastrostomy in Alzheimer's disease and senile dementia of the Alzheimer's type cases
NEUROBIOLOGY OF AGING 1998; 19(4S): 21 1998/07-08
Takahashi M, Tsujioka Y, Yamada T, Tsuboi Y, Okada H, Yamamoto T, and Liposits Z.
Glycosylation of microtubule-associated protein tau in Alzheimerﾕs disease brain.
Acta Neuropathol (Berl) 1999 Jun;97(6):635-41
Imre F, Baranyi L, Kaneko Y, Liposits Z, Yamamoto T, and Okada H.
C5a receptor expression by TGW neuroblastoma cells.
Neuroreport 1999 Sep 29;10(14):3021-5
Matsukawa N, Tooyama I, Kimura H, Yamamoto T, Tsugu Y, Oomura Y, and Ojika K.
Increased expression of hippocampal cholinergic neurostimulating peptide (HCNP)-related components and mRNA in the hippocampus of aged senescence accelerated mice (SAM).
Neuroscience 1999 Jan;88(1):79-92
Oshima T, Okada N, Joh T, Sasaki M, Tada T, Matsukawa N, Nomura T, Ohara H, Itoh M, and Okada H.
Decay-accelerating factor in guinea pig stomachs following ishemia reperfusion stress.
J. Immunol. 164: 1078-1085 (2000)
Sato T, Miwa T, Akatsu H, Matsukawa N, Obata K, Okada N, Campbell W, and Okada H.
Pro-carboxypeptidase R is an acute phase protein in the mouse, whereas carboxypeptidase N is not.
J Immunol 2000 Jul 15;165(2):1053-8
Kato T, Akatsu H, Sato T, Matsuo S, Yamamoto T, Campbell W, Hotta N, Okada N, and Okada H.
Molecular cloning and partial characterization of rat procarboxypeptidase R and carboxypeptidase N.
Microbiol Immunol 2000;44(8):719-28
Dean YD, McGreal EP, Akatsu H, Gasque P.
Molecular and cellular properties of the rat AA4 antigen, a C-type lectin-like receptor with structural homology to thrombomodulin.
J Biol Chem;275:34382-92.(2000)
Kanie J, Kono K, Kono T, Osawa M, Yamamoto T, Akatsu H, Shimokata H, and Iguchi A.
[Complications of percutaneous endoscopic gastrostomy in the elderly: local skin infection and respiratory infection].
Nippon Ronen Igakkai Zasshi 37:143. 2000.
Ogawa K, Yamada T, Tsujioka Y, Taguchi J, Takahashi M, Tsuboi Y, Fujino Y, Nakajima M, Yamamoto Y, Akatsu H, Mitsui S, and Yamaguchi N.
Localization of a novel type trypsin-likeserine protease, neurosin, in brain of Alzheimer`s disease and Parkinson` s disease.
Psychiatry and Clinical Neurosciences 54:419-426. 2000.
Horimoto Y, Aiba I, Yasuda T, Ohkawa Y, Katayama T, Yokokawa Y, Goto A, and Ito Y
Cerebral atrophy in multiple system atrophy by MRI
J Neurol Sci 2000 Feb 15;173(2):109-12
Umegaki H, Ikari H, Nakahata H, Yoshimura J, Endo H, Yamamoto T, and Iguchi A.
Low plasma epinephrine in elderly female subjects of dementia of Alzheimer type.
Brain Res 2000 Mar 6;858(1):67-70
Umegaki H, Ikari H, Nakahata H, Endo H, Suzuki Y, Ogawa O, Nakamura A, Yamamoto T, and Iguchi A.
Plasma cortisol levels in elderly female subjects with Alzheimer's disease: acrosssectional and longitudinal study.
Brain Res 2000 Oct 27;881(2):241-3
蟹江治郎、河野和彦、河野勤、大澤雅子、山本孝之、赤津裕康、下方浩史、井口昭久
高齢者に対する経皮内視鏡的胃瘻造設術における合併症：創部感染症と呼吸器感染症の検討
日本老年医学会誌 2000; 37: 143-148 2000/04
蟹江治郎、河野勤、大澤雅子、赤津裕康、山本孝之、下方浩史、井口昭久
経皮内視鏡的胃瘻造設術術後、経管栄養を離脱し得た症例に対しての検討
在宅治療と内視鏡治療 2000/07/29 2000/07
Masumura M, Hata R, Akatsu H, Kosaka K, Yamamoto T Nagai Y, and Sawada T.
Increasing in situ nick end labeling of oligodendrocyte in white matter of patient with Binswanger`s disease
Journal of Stroke and Cerebrovascular disease 2001 vol.10 page 55
Abe M, Shibata K, Akatsu H, Shimizu N, Sakata N, Katsuragi T, and Okada H.
Contribution of anaphylatoxin C5a to late airway responses following repeated exposure of antigen to allergic rats.
J Immunol 2001 Oct 15;167(8):4651-60
Hata R, Masumura M, Akatsu H, Li F, Fujita H, Nagai Y, Yamamoto T,Okada H, Kosaka K, Sakanaka M, and Sawada T.
Up-Regulation of Calcineurin Abeta mRNA in the Alzheimer's Disease Brain: Assessment by cDNA Microarray.
Biochem Biophys Res Commun 284: 310-6., 2001
堀本佳彦、松本光弘、赤津裕康、伊苅弘之、山本孝之、小阪憲司、大塚康史、上田龍三、小鹿幸生
レビー小体病剖検例の臨床像
第101回日本神経学会東海北陸地方会
Heese K, Nakayama T, Hata R, Masumura M, Akatsu H, Li F, Nagai Y, Yamamoto T, Kosaka K, Suemoto T, and Sawada T.
Characterizing CGI-94 (comparative gene identification-94) which is down-regulated in the hippocampus of early stage Alzheimer's disease brain
Eur J Neurosci 2002 Jan;15(1):79-86
Tsuboi Y, Kakimoto K, Akatu H, Daikuhara Y, Yamada T.
Hepatocyte growth factor in cerebrospinal fluid in neurologic disease.
Acta Neurol Scand 2002 Aug;106(2):99-103
Umegaki H, Ushida C, Ikari H, Ogawa O, Nakamura A, Suzuki Y, Endo H, Akatsu H, Yamamoto T, Iguchi A.
Plasma Insulin and Glucose Levels in Elderly Female Subjects with Alzheimer's disease,
Geriatrics and Gerontology International 2002 vol 2, p75-79
McGreal EP, Ikewaki N, Akatsu H, Morgan BP, Gasque P.
Human C1qRp is identical with CD93 and the mNI-11 antigen but does not bind C1q.
J Immunol 2002 May 15;168(10):5222-32
Akatsu H, Takahashi M, Matsukawa N, Ishikawa Y, Kondo N, Sato T, Yamada T, Okada H, Yamamoto T, Kosaka K.
Subtype analysis of neuropathologically diagnosed patients in a Japanese geriatric hospital.
J Neurol Sci 2002 Apr 15;196(1-2):63-9
Ikeguchi H, Maruyama S, Morita Y, Fujita Y, Kato T, Natori Y, Akatsu H, Campbell W, Okada N, Okada H, Yuzawa Y, Matsuo S.
Effects of human soluble thrombomodulin on experimental glomerulonephritis.
Kidney Int 2002 Feb;61(2):490-501
Maki M, Matsukawa N, Yuasa H, Otsuka Y, Yamamoto T, Akatsu H, Okamoto T, Ueda R, Ojika K.
Decreased expression of hippocampal cholinergic neurostimulating peptide precursor protein mRNA in the hippocampus in Alzheimer disease.
J Neuropathol Exp Neurol 2002 Feb;61(2):176-85
Maeda S, Takeyama H, Okada H, Manabe T.
MUC1 Mucin Directly Binds to Tissue Culture Plates and Is Detectable with Antibody to MUC1 Core Protein
Nagoya medical journal (in press)
Farkas I, Baranyi L, Ishikawa Y, Okada N, Bohata C, Budai D, Fukuda A, Imai M, and Okada H.
CD59 blocks not only the insertion of C9 into MAC but inhibits ion channel formation by homologous C5b-8 as well as C5b-9,
J Physiol, 539 (2002) 537-545.
蟹江治郎、赤津裕康、山本孝之、葛谷雅文、井口昭久
Pull法またはPush法による経皮内視鏡的胃瘻造設術手技の工夫 -チューブ位置確認を目的とした内視鏡再挿入の必要性に対する検討-
在宅治療と内視鏡治療 2002; in press.
Iseki E, Tsunoda S, Suzuki K, Takayama N, Akatsu H, Yamamoto T, Kosaka K.
Regional quantitative analysis of NFT in brains of non-demented elderly persons: comparisons with findings in brains of late-onset Alzheimer's disease and limbic NFT dementia.
Neuropathology 2002 Mar;22(1):34-9
Kanie J, Akatsu H, Suzuki Y, Shimokata H, Iguchi A.
Mechanism of the development of gastric ulcer after percutaneous endoscopic gastrostomy.
Endoscopy 2002 Jun;34(6):480-3
Kanie J, Kaganu C, Yamamoto T, Akatsu H, Suzuki Y, Kuzuya M, Igucgi A.
[Half-solid enteral nutrient prevents chronic complications of percutaneous endoscopic gastrostomy tube feeding]
Nippon Ronen Igakkai Zasshi 2002 Jul;39(4):448-51
Akatsu H, Abe M, Miwa T, Tateyama H, Maeda S, Okada N, Kojima K, Okada H.
Distribution of Rat C5a Anaphylatoxin Receptor.
Microbiol Immunol 2002;46(12):863-874
Matsumoto M, Kosaka K, Horimoto Y, Akatsu H, Yamamoto T, Matsukawa N, Ueda R, Ojika K.
A clinicopathological study of idiopathic normal pressure hydrocephalus.
Psychogeriatrics 2002;2:289-294
Kanie J, Akatsu H, Suzuki Y, Shimokata H, Iguchi A.
Mechanism of the development of gastric ulcer after percutaneous endoscopic gastrostomy
Endoscopy. 2002 Jun;34(6):480-2.
蟹江治郎、赤津裕康、山本孝之、葛谷雅文、井口昭久
Pull法またはPush法による経皮内視鏡的胃瘻造設術手技の工夫 - ﾁｭｰﾌﾞ位置確認を目的とした内視鏡再挿入の必要性に対する検討 -
在宅治療と内視鏡治療 2002 Vol.6 17-20
蟹江治郎、各務千鶴子、山本孝之、赤津裕康、鈴木裕介、葛谷雅文、井口昭久
固形化経腸栄養剤の投与により胃瘻栄養の慢性期合併症を改善し得た１例
日本老年医学会誌 2002; 39: 448-451
Tsuboi Y, Kakimoto K, Nakajima M, Akatsu H, Yamamoto T, Ogawa K, Ohnishi T, Daikuhara Y, Yamada T.
Increased hepatocyte growth factor level in cerebrospinal fluid in Alzheimer's disease.
Acta Neurol Scand. 2003 Feb;107(2):81-6.
Lu Q, Kanai Y, Kubota T.
The emergence of anti-dsDNA antibodies precedes nucleosome-specific antibodies in MRL/lpr and MRL/+ mice.
J Med Dent Sci. 2003 Mar;50(1):9-15.
Iseki E, Togo T, Suzuki K, Katsuse O, Marui W, de Silva R, Lees A, Yamamoto T, Kosaka K.
Dementia with Lewy bodies from the perspective of tauopathy.
Acta Neuropathol (Berl). 2003 Mar;105(3):265-70. Epub 2002 Nov 22.
Togo T, Iseki E, Shoji M, Oyama I, Kase A, Uchikado H, Katsuse O, Kosaka K.
Prolactin levels in schizophrenic patients receiving perospirone in comparison to risperidone.
J Pharmacol Sci. 2003 Mar;91(3):259-62.
Katsuse O, Iseki E, Kosaka K.
Immunohistochemical study of the expression of cytokines and nitric oxide synthases in brains of patients with dementia with Lewy bodies.
Neuropathology. 2003 Mar;23(1):9-15.
Kishida I, Kawanishi C, Furuno T, Matsumura T, Hasegawa H, Sugiyama N, Suzuki K, Yamada Y, Kosaka K.
Lack of association in Japanese patients between neuroleptic malignant syndrome and the TaqI A polymorphism of the dopamine D2 receptor gene.
Psychiatr Genet. 2003 Mar;13(1):55-7.
Suzuki K, Iseki E, Katsuse O, Yamaguchi A, Katsuyama K, Aoki I, Yamanaka S, Kosaka K.
Neuronal accumulation of alpha- and beta-synucleins in the brain of a GM2 gangliosidosis mouse model.
Neuroreport. 2003 Mar 24;14(4):551-4.
Horimoto Y, Matsumoto M, Akatsu H, Ikari H, Kojima K, Yamamoto T, Otsuka Y, Ojika K, Ueda R, Kosaka K.
Autonomic dysfunctions in dementia with Lewy bodies.
J Neurol. 2003 May;250(5):530-3.
Yamaguchi A, Katsuyama K, Suzuki K, Kosaka K, Aoki I, Yamanaka S.
Plasmid-based gene transfer ameliorates visceral storage in a mouse model of Sandhoff disease.
J Mol Med. 2003 Mar;81(3):185-93. Epub 2003 Feb 12.
Marui W, Iseki E, Kato M, Kosaka K.
Degeneration of tyrosine hydroxylase-immunoreactive neurons in the cerebral cortex and hippocampus of patients with dementia with Lewy bodies.
Neurosci Lett. 2003 Apr 17;340(3):185-8.
Tani S, Akatsu H, Ishikawa Y, Okada N, Okada H.
Preferential detection of pro-carboxypeptidase R by enzyme-linked immunosorbent assay.
Microbiol Immunol. 2003;47(4):295-300.
Shibuya K, Uchihara T, Nakamura A, Ishiyama M, Yamaoka K, Yagishita S, Iwabuchi K, Kosaka K.
Reversible conformational change of tau2 epitope on exposure to detergent in glial cytoplasmic inclusions of multiple system atrophy.
Acta Neuropathol (Berl). 2003 May;105(5):508-14. Epub 2003 Feb 26.
Farkas I, Takahashi M, Fukuda A, Yamamoto N, Akatsu H, Baranyi L, Tateyama H, Yamamoto T, Okada N, Okada H.
Complement C5a Receptor-Mediated Signaling May Be Involved in Neurodegeneration in Alzheimer’s Disease
J Immunol. 2003 Jun 1;170(11):5764-71.
Odawara T, Shiozaki K, Iseki E, Hino H, Kosaka K.
Alterations of muscarinic acetylcholine receptors in atypical Pick's disease without Pick bodies.
J Neurol Neurosurg Psychiatry. 2003 Jul;74(7):965-7.
Katsuse O, Iseki E, Marui W, Kosaka K.
Developmental stages of cortical Lewy bodies and their relation to axonal transport blockage in brains of patients with dementia with Lewy bodies.
J Neurol Sci. 2003 Jul 15;211(1-2):29-35.
Kanai Y.
The role of non-chromosomal histones in the host defense system.
Microbiol Immunol. 2003;47(8):553-6.
Katsuse O, Iseki E, Arai T, Akiyama H, Togo T, Uchikado H, Kato M, de Silva R, Lees A, Kosaka K.
4-repeat tauopathy sharing pathological and biochemical features of corticobasal degeneration and progressive supranuclear palsy.
Acta Neuropathol (Berl). 2003 Sep;106(3):251-60. Epub 2003 Jun 11.
Umegaki H, Ishiwata K, Ogawa O, Ingram DK, Roth GS, Oda K, Kurotani S, Kawamura K, Wang WF, Ikari H, Senda M, Iguchi A.
Longitudinal follow-up study of adenoviral vector-mediated gene transfer of dopamine D2 receptors in the striatum in young, middle-aged, and aged rats: a positron emission tomography study.
Neuroscience. 2003;121(2):479-86.
Horimoto Y, Matsumoto M, Nakazawa H, Yuasa H, Morishita M, Akatsu H, Ikari H, Yamamoto T, Kosaka K.
Cognitive conditions of pathologically confirmed dementia with Lewy bodies and Parkinson disease with dementia.
J Neurol Sci. 2003 Dec 15;216(1):105-8.
Kanai Y and Akatsu H.
Normal immune response to histone-related nuclear antigens in senile dementia such as Alzheimer's disease.
Proc Jap Soci Immunol 2003; 33: pp 202
Odawara T, Iseki E, Kanai A, Arai T, Katsuragi T, Hino H, Furukawa Y, Kato M, Yamamoto T, Kosaka K.
Clinicopathological study of two subtypes of Pick's disease in Japan.
Dement Geriatr Cogn Disord. 2003;15(1):19-25.
Francis K, Lewis BM, Akatsu H, Monk PN, Cain SA, Scanlon MF, Morgan BP, Ham J, Gasque P.
Complement C3a receptors in the pituitary gland: a novel pathway by which an innate immune molecule releases hormones involved in the control of inflammation.
FASEB J. 2003 Dec;17(15):2266-8. Epub 2003 Oct 16.
Takahashi E, Tateyama H, Akatsu H, Fukai I, Yamakawa Y, Fujii Y, Eimoto T.
Expression of matrix metalloproteinases 2 and 7 in tumor cells correlates with the World Health Organization classification subtype and clinical stage of thymic epithelial tumors.
Hum Pathol. 2003 Dec;34(12):1253-8.
堤 玲子、相原道子、石和万美子、高橋一夫、大西秀樹、山田和夫、木村博和、小阪憲司、池澤善郎
アトピー性皮膚炎患者における適応障害（第１報）－精神医学的実態について－
日本皮膚科学会雑誌 2003;113:19-24
堤 玲子、相原道子、石和万美子、高橋一夫、大西秀樹、山田和夫、木村博和、小阪憲司、池澤善郎
アトピー性皮膚炎患者における適応障害（第２報）－２症例における介入の実際－
日本皮膚科学会雑誌 2003;113:25-30
小阪憲司
アルツハイマー病の診断基準
診断と治療 2003;91:231-235
都甲 崇、井関栄三、加瀬昭彦、内門大丈、勝瀬大海、小阪憲司
Olauzapineが奏効した躁病の１症例
精神医学 2003;45(2):183-186
松本俊彦、山口亜希子、上篠敦史、南堤一、遠藤桂子、矢花辰夫、岸本英 、小阪憲司
女性物質使用障害における摂取障害―乱用物質と摂取障害の関係について
精神医学 2003;45:119-127
丸井和美、井関栄三、中野光子、小阪憲司
塩酸ドネペジルにより頸部ジストニアとパーキソニズムの顕在化をみたパーキンソン病の１例
精神科治療学 2003;18:185-189
小田原俊成、小阪憲司
フルボキサミンがBPSDに有効であった痴呆症例をめぐって
分子精神医学 2003;3:83-84，
岡村信行、末元隆寛、工藤幸司、澤田 徹、荒井啓行、佐々木英忠、赤津裕康、山本孝之
ADの画像診断：生体における脳アミロイドイメージング技術の開発
遺伝子医学 23号 2003.3 Vol.7 No.1
丸井和美、井関栄三、杉山直也、松村雄彦、鈴木京子、小田原俊成、日野博昭、小阪憲司
プレセニリン１遺伝子異常を伴う家族性アルツハイマー病の１家系―家系内での発症年齢の若年化とApoE遺伝子多型について―
脳と神経 2003;55:349-353
蟹江治郎、赤津裕康、各務千鶴子
経腸栄養剤固形化によるＰＥＧ後期合併症への対策
臨床看護 2003;29(5):664-670
小阪憲司
私の恩師「猪瀬先生」
最新精神医学 2003;8(6);605
塩崎一昌、日野博昭、瀬川光子、角田卓治、小阪憲司
横浜市における痴呆性高齢者緊急一時入院制度により緊急入院を要した高齢者の特徴とその問題点
老年精神医学雑誌 2003;14:891-897
小阪憲司
新しい病気の発見
脳の科学 2003;25:1019-1022
Suemoto T, Okamura N, Shiomitsu T, Suzuki M, Shimadzu H, Akatsu H, Yamamoto T, Kudo Y, Sawada T
In vivo labeling of amyloid with BF-108.
Neurosci Res. 2004 Jan;48(1):65-74.
Okamura N, Suemoto T, Shimadzu H, Suzuki M, Shiomitsu T, Akatsu H, Yamamoto T, Staufenbiel M, Yanai K, Arai H, Sasaki H, Kudo Y, Sawada T
Styrylbenzoxazole derivatives for in vivo imaging of amyloid plaques in the brain.
J Neurosci. 2004 Mar 10;24(10):2535-41.
Heese K, Yamada T, Akatsu H, Yamamoto T, Kosaka K, Nagai Y, Sawada T.
Characterizing the new transcription regulator protein p60TRP.
J Cell Biochem. 2004 Apr 1;91(5):1030-42.
Akatsu H, Kamino K, Yamagata H, Isojima D, Kondo I, Yamamoto T, Kida T, Takeda M, Miki T and Kosaka K
Increased incidence of dementia with Lewy bodies in patients carrying the ∈4-allele of apolipoprotein E
Psychogeriatrics, June 2004, vol. 4, no. 2, pp. 24-32(9)
Marui W, Iseki E, Kato M, Akatsu H, Kosaka K.
Pathological entity of dementia with Lewy bodies and its differentiation from Alzheimer's disease.
Acta Neuropathol (Berl). 2004 Aug;108(2):121-8. Epub 2004 May 14.
Yamagata H, Chen Y, Akatsu H, Kamino K, Ito J, Yokoyama S, Yamamoto T, Kosaka K, Miki T, Kondo I.
Promoter polymorphism in fibroblast growth factor 1 gene increases risk of definite Alzheimer's disease.
Biochem Biophys Res Commun. 2004 Aug 20;321(2):320-3.
Okamura N, Suemoto T, Shiomitsu T, Suzuki M, Shimadzu H, Akatsu H, Yamamoto T, Arai H, Sasaki H, Yanai K, Staufenbiel M, Kudo Y, Sawada T.
A novel imaging probe for in vivo detection of neuritic and diffuse amyloid plaques in the brain.
J Mol Neurosci. 2004;24(2):247-56.
Heese K, Fujita M, Akatsu H, Yamamoto T, Kosaka K, Nagai Y, Sawada T.
The Splicing Regulatory Protein p18SRP Is Down-Regulated in Alzheimer's Disease Brain.
J Mol Neurosci. 2004;24(2):269-76.
Akatsu H, Yamagata H, Chen Y, Miki T, Kamino K, Takeda M, Campbell W, Kondo I, Kosaka K, Yamamoto T, Okada H.
TAFI polymorphisms at amino acids 147 and 325 are not risk factors for cerebral infarction.
Br J Haematol. 2004 Nov;127(4):440-7.
Kanie J, Suzuki Y, Akatsu H, Kuzuya M, Iguchi A.
Prevention of late complications by half-solid enteral nutrients in percutaneous endoscopic gastrostomy tube feeding.
Gerontology. 2004 Nov-Dec;50(6):417-9.
Taguchi K, Yamagata H, Zhong W, Kamino K, Akatsu H, Hata R, Yamamoto T, Kosaka K, Takeda M, Kondo I, Miki T
Identification of hippocampus-related candidate genes for Alzheimer's disease.
Ann Neurol. 2005 Apr;57(4):585-8.
Zhong W, Yamagata HD, Taguchi K, Akatsu H, Kamino K, Yamamoto T, Kosaka K, Takeda M, Kondo I, Miki T.
Lymphocyte-specific protein tyrosine kinase is a novel risk gene for Alzheimer disease.
J Neurol Sci. 2005 Aug 15
Satoh K, Hata M, Shimizu T, Yokota H, Akatsu H, Yamamoto T, Kosaka K, Yamada T.
Lib, transcriptionally induced in senile plaque-associated astrocytes, promotes glial migration through extracellular matrix.
Biochem Biophys Res Commun. 2005 Sep 23;335(2):631-6.
Okamura N, Suemoto T, Furumoto S, Suzuki M, Shimadzu H, Akatsu H, Yamamoto T, Fujiwara H, Nemoto M, Maruyama M, Arai H, Yanai K, Sawada T, Kudo Y.
Quinoline and benzimidazole derivatives: candidate probes for in vivo imaging of tau pathology in Alzheimer's disease.
BF Research Institute, Osaka 541-0045, Japan.
Fujishiro H, Umegaki H, Isojima D, Akatsu H, Iguchi A, Kosaka K.
Depletion of cholinergic neurons in the nucleus of the medial septum and the vertical limb of the diagonal band in dementia with Lewy bodies.
Acta Neuropathol (Berl). 2006 Feb;111(2):109-14. Epub 2006 Jan 19.
Clewing JM, Antalfy BC, Lucke T, Najafian B, Marwedel KM, Hori A, Powel RM, Safo Do AF, Najera L, SantaCruz K, Hicks MJ, Armstrong DL, Boerkoel CF.
Schimke immuno-osseous dysplasia: a clinicopathological correlation.
J Med Genet. 2007 Feb;44(2):122-30. Epub 2006 Jul 13.
Kimura R, Kamino K, Yamamoto M, Kida T, Akatsu H, Uema T, Kobayashi T, Hattori H, Nuripa A, Nessa BN, Kazui H, Ikejiri Y, Tanaka T, Tanii H, Kudo T, Yoneda H, Yamagata H, Miki T, Takeda M.
Albumin gene encoding free fatty acid and beta-amyloid transporter is genetically associated with Alzheimer disease.
Psychiatry Clin Neurosci. 2006 Apr;60 Suppl 1:S34-9.
Dammann O, Hori A, Szentiks C, Hewicker-Trautwein M.
Absence of pestivirus antigen in brains with white matter damage.
Dev Med Child Neurol. 2006 Apr;48(4):290-3.
Akatsu H, Yamagata HD, Kawamata J, Kamino K, Takeda M, Yamamoto T, Miki T, Tooyama I, Shimohama S, Kosaka K.
Variations in the BDNF Gene in Autopsy-Confirmed Alzheimer's Disease and Dementia with Lewy Bodies in Japan
Dement Geriatr Cogn Disord. 2006;22(3):216-22. Epub 2006 Aug 7.
Wollmer, M.A., Kapaki, E., Hersberger, M., Muntwyler, J., Brunner, F., Tsolaki, M., Akatsu, H., Kosaka, K., Michikawa, M., Molyva, D., Paraskevas, G.P., Lutjohann, D., von Eckardstein, A., Hock, C., Nitsch, R.M., Papassotiropoulos, A.
Ethnicity-dependent genetic association of ABCA2 with sporadic Alzheimer's disease.
Am J Med Genet B Neuropsychiatr Genet. 2006 Jul 5;141(5):534-6.
Heese K, Akatsu H.
Alzheimer's disease--an interactive perspective.
Curr Alzheimer Res. 2006 Apr;3(2):109-21.
Isojima D, Togo T, Kosaka K, Fujishiro H, Akatsu H, Katsuse O, Iritani S, Matsumoto T, Hirayasu Y.
Vascular complications in dementia with Lewy bodies: a postmortem study
Neuropathology. 2006 Aug;26(4):293-7.
Mitsuda N, Yamagata HD, Zhong W, Aoto M, Akatsu H, Uekawa N, Kamino K, Taguchi K, Yamamoto T, Maruyama M, Kosaka K, Takeda M, Kondo I, Miki T.
A novel alternative splice variant of nicastrin and its implication in Alzheimer disease.
Life Sci. 2006 Apr 18;78(21):2444-8. Epub 2005 Nov 21.
Satoh K, Hata M, Takahara S, Tsuzaki H, Yokota H, Akatsu H, Yamamoto T, Kosaka K, Yamada T.
A novel membrane protein, encoded by the gene covering KIAA0233, is transcriptionally induced in senile plaque-associated astrocytes.
Brain Res. 2006 Jul 17
Waragai M, Wei J, Fujita M, Nakai M, Ho GJ, Masliah E, Akatsu H, Yamada T, Hashimoto M.
Increased level of DJ-1 in the cerebrospinal fluids of sporadic Parkinson's disease.
Biochem Biophys Res Commun. 2006 Jul 7;345(3):967-72. Epub 2006 May 11.
Kimura R, Kamino K, Yamamoto M, Nuripa A, Kida T, Kazui H, Hashimoto R, Tanaka T, Kudo T, Yamagata H, Tabara Y, Miki T, Akatsu H, Kosaka K, Funakoshi E, Nishitomi K, Sakaguchi G, Kato A, Hattori H, Uema T, Takeda M.
The DYRK1A gene, encoded in chromosome 21 Down syndrome critical region, bridges between {beta}-amyloid production and tau phosphorylation in Alzheimer disease.
Hum Mol Genet. 2006 Nov 29
Yokota T, Mishra M, Akatsu H, Tani Y, Miyauchi T, Yamamoto T, Kosaka K, Nagai Y, Sawada T, Heese K.
Brain site-specific gene expression analysis in Alzheimer's disease patients.
Eur J Clin Invest. 2006 Nov;36(11):820-30.
Petri S, Kollewe K, Grothe C, Hori A, Dengler R, Bufler J, Krampfl K.
GABA(A)-receptor mRNA expression in the prefrontal and temporal cortex of ALS patients.
J Neurol Sci. 2006 Dec 1;250(1-2):124-32. Epub 2006 Oct 2.
Hori A.
Causes of neuronal heterotopia other than migration disturbances.
Neuropathology. 2006 Dec;26(6):540-3.
Hori A.
Kapitel 4. Entwicklung des Zentralnervensystems.
In: Biedermann H (Hrsg) Manuelle Therapie bei Kindern. Indikation und Konzepte. Elsevier/Urban & Fischer, Munchen・Jena, March 2006 S.27-40
ten Donkelaar HJ, Mullaart RA, Hori A, Shiota K.
Chapter 4. Neurulation and neural tube defects.
In: ten Donkelaar HJ, Lammens M, Hori A: Clinical Neuroembryology: Development and developmental disorders of the human central nervous system.
Springer, Heidelberg-Berlin,Wien, New York-Tokyo, 2006, pp145-190
ten Donkelaar HJ, Hori A.
Chapter 6. Development and developmental disorders of the spinal cord.
In: ten Donkelaar HJ, Lammens M, Hori A: Clinical euroembryology: Development and developmental disorders of the human central nervous system.
Springer, Heidelberg-Berlin,Wien, New York-Tokyo, 2006, pp229-268
ten Donkelaar HJ, Lammens M, Wesseling P, Hori A.
Chapter 8. Development and developmental disorders of the human cerebellum.
In: ten Donkelaar HJ, Lammens M, Hori A: Clinical Neuroembryology: Development and developmental disorders of the human central nervous system.
Springer, Heidelberg-Berlin,Wien, New York-Tokyo, 2006, pp309-344
ten Donkelaar HJ, Lammens M, Cruysberg JRM, Hori A, Shiota K.
Chapter 9. Development and developmental disorders of the forebrain.
In: ten Donkelaar HJ, Lammens M, Hori A: Clinical Neuroembryology: Development and developmental disorders of the human central nervous system.
Springer, Heidelberg-Berlin,Wien, New York-Tokyo, 2006, pp345-428
ten Donkelaar HJ, Lammens M, Renier W, Hori A.
Chapter 10. Development and developmental disorders of the cerebral cortex.
In: ten Donkelaar HJ, Lammens M, Hori A: Clinical Neuroembryology: Development and developmental disorders of the human central nervous system.
Springer, Heidelberg-Berlin,Wien, New York-Tokyo, 2006. pp429-518
Makino S, Kaji R, Ando S, Tomizawa M, Yasuno K, Goto S, Matsumoto S, Tabuena MD, Maranon E, Dantes M, Lee LV, Ogasawara K, Tooyama I, Akatsu H, Nishimura M, Tamiya G.
Reduced Neuron-Specific Expression of the TAF1 Gene Is Associated with X-Linked Dystonia-Parkinsonism.
Am J Hum Genet. 2007 Mar;80(3):393-406. Epub 2007 Jan 23.
Akatsu H, Ishiguro M, Ogawa N, Kanesaka T, Okada N, Yamamoto T, Campbell W, Okada H.
Plasma Levels of Unactivated Thrombin Activatable Fibrinolysis Inhibitor (TAFI) Are Down-Regulated in Young Adult Women: Analysis of a Normal Japanese Population.
Microbiol Immunol. 2007;51(5):507-17.
Rittierodt M, Hori A.
Pre-morbid morphological conditions of the human pituitary.
Neuropathology. 2007 Feb;27(1):43-8.
小西吉裕、堀 映
欧米におけるリサーチリソース確保（とくにブレインバンク）と運用の実状 ―わが国でのそれの効率的運用の為に―
神経・筋疾患と慢性精神疾患等のリサーチ・リソース（剖検脳の組織）の確保とそのシステム整備に関する研究（16指―4）
総括研究実績報告書（平成16―18年度）116-118, March 2007
赤津裕康、松本光弘、宮本圭子、山本淑子、芦田欣也、高見正雄、小橋修
胃瘻患者への短期間のたんぱく質強化による栄養介入効果とインフルエンザワクチン抗体価に及ぼす影響
栄養評価と治療 Vol24,No.3
Nakai M, Fujita M, Waragai M, Sugama S, Wei J, Akatsu H, Ohtaka-Maruyama C, Okado H, Hashimoto M.
Expression of alpha-synuclein, a presynaptic protein implicated in Parkinson's disease, in erythropoietic lineage.
Biochem Biophys Res Commun. 2007 Jun 22;358(1):104-10. Epub 2007 Apr 25.
Wei J, Fujita M, Nakai M, Waragai M, Watabe K, Akatsu H, Rockenstein E, Masliah E, Hashimoto M.
Enhanced lysosomal pathology caused by beta -synuclein mutants linked to dementia with lewy bodies.
J Biol Chem. 2007 Jul 24;
Waragai M, Nakai M, Wei J, Fujita M, Mizuno H, Ho G, Masliah E, Akatsu H, Yokochi F, Hashimoto M.
Plasma levels of DJ-1 as a possible marker for progression of sporadic Parkinson's disease.
Neurosci Lett. 2007 Aug 11
Zou K, Yamaguchi H, Akatsu H, Sakamoto T, Ko M, Mizoguchi K, Gong JS, Yu W, Yamamoto T, Kosaka K, Yanagisawa K, Michikawa M.
Angiotensin-converting enzyme converts amyloid beta-protein 1-42 (Abeta(1-42)) to Abeta(1-40), and its inhibition enhances brain Abeta deposition.
J Neurosci. 2007 Aug 8;27(32):8628-35.
Kanai Y, Akatsu H, Iizuka H, Morimoto C.
Could serum antibody to poly(ADP-ribose) and/or histone H1 be marker for senile dementia of Alzheimer type?
Ann N Y Acad Sci. 2007 Aug;1109:338-44.
堀 映
脳の発達：正常と異常（特集 実地病理医に必要な神経病理II 変性・炎症・小児）
病理と臨床 25(11):1139-1147 2007
Clewing JM, Antalfy BC, Lu"cke T, Najafian B, Marwedel KM, Hori A, Powel RM, Do AF, Najera L, SantaCruz K, Hicks MJ, Armstrong DL, Boerkoel CF.
Schimke immuno-osseous dysplasia: a clinicopathological correlation.
J Med Genet. 2007 Feb;44(2):122-30. Epub 2006 Jul 13.
Okamura N, Furumoto S, Funaki Y, Suemoto T, Kato M, Ishikawa Y, Ito S, Akatsu H, Yamamoto T, Sawada T, Arai H, Kudo Y and Yanai K.
Binding and safety profile of novel benzoxazole derivative for in vivo imaging of amyloid deposits in Alzheimer's disease
Geriatrics & Gerontology International. Volume 7 Issue 4 Page 393-400, December 2007
Hiroshige FUJISHIRO, Hiroyuki UMEGAKI, Yusuke SUZUKI, Daisuke ISOJIMA, Hiroyasu AKATSU, Hiroyuki IKARI, Akihisa IGUCHI and Kenji KOSAKA
Clinical profiles of autopsy-confirmed dementia with Lewy bodies at institutionalization: Comparison with Alzheimer’s disease
Psychogeriatrics Volume 7 Issue 3 Page 98-103, September 2007
Nozaki I, Watanabe T, Kawaguchi M, Akatsu H, Tsuneyama K, Yamamoto Y, Ohe K, Yonekura H, Yamada M, Yamamoto H.
Reduced expression of endogenous secretory receptor for advanced glycation endproducts in hippocampal neurons of Alzheimer's disease brains.
Arch Histol Cytol. 2007 Dec;70(5):279-90.
Aidaralieva NJ, Kamino K, Kimura R, Yamamoto M, Morihara T, Kazui H, Hashimoto R, Tanaka T, Kudo T, Kida T, Okuda J, Uema T, Yamagata H, Miki T, Akatsu H, Kosaka K, Takeda M.
Dynamin 2 gene is a novel susceptibility gene for late-onset Alzheimer disease in non-APOE-epsilon4 carriers.
J Hum Genet. 2008;53(4):296-302. Epub 2008 Jan 31
堀 映
乳幼児虐待の背景にある要因について―12例の解析―
鳥取臨床科学研究会誌 1(1): 95-100 2008
Komatsu F, Farkas I, Akatsu H, Kojima K, Fukushima T, Okada H.
Potential neural progenitor cells in fetal liver and regenerating liver.
Cytotechnology. 2008 Mar;56(3):209-17. Epub 2008 Jun 5.
Liu Y, Mimuro M, Yoshida M, Hashizume Y, Niwa H, Miyao S, Ujihira N, Akatsu H.
Inclusion-positive cell types in adult-onset intranuclear inclusion body disease: implications for clinical diagnosis.
Acta Neuropathol. 2008 Dec;116(6):615-23. Epub 2008 Oct 16.
Taniguchi M, Okayama Y, Hashimoto Y, Kitaura M, Jimbo D, Wakutani Y, Wada-Isoe K, Nakashima K, Akatsu H, Furukawa K, Arai H, Urakami K.
Sugar chains of cerebrospinal fluid transferrin as a new biological marker of Alzheimer's disease.
Dement Geriatr Cogn Disord. 2008;26(2):117-22. Epub 2008 Jul 24.
赤津裕康、宮本圭子、山本淑子、堀映、小橋修、小阪憲司、山本孝之
福祉村病院における栄養サポートチーム（NST）の介入が及ぼした影響について
鳥取臨床科学研究会雑誌1(1), 47-53 (2008)
石黒雅江
LAK-T療法の向神経作用
Biotherapy 23(1):21-27,January,2009
赤津裕康、伊苅弘之、松山善次郎、小橋修、瀬藤光利、山本孝之
高カロリー輸液にて栄養管理している高齢者における栄養・微量元素の推移に関する研究
新薬と臨床 第58巻第11号別冊 2009.11.10
Okita K, Matsukawa N, Maki M, Nakazawa H, Katada E, Hattori M, Akatsu H, Borlongan CV, Ojika K.
Analysis of DNA variations in promoter region of HCNP gene with Alzheimer's disease.
Biochem Biophys Res Commun. 2008 Dec 25.
Fukumoto N, Fujii T, Combarros O, Kamboh MI, Tsai SJ, Matsushita S, Nacmias B, Comings DE, Arboleda H, Ingelsson M, Hyman BT, Akatsu H, Grupe A, Nishimura AL, Zatz M, Mattila KM, Rinne J, Goto YI, Asada T, Nakamura S, Kunugi H.
Sexually dimorphic effect of the Val66Met polymorphism of BDNF on susceptibility to Alzheimer's disease: New data and meta-analysis.
Am J Med Genet B Neuropsychiatr Genet. 2009 Jun 5.
Kimura R, Yamamoto M, Morihara T, Akatsu H, Kudo T, Kamino K, Takeda M.
SORL1 is genetically associated with Alzheimer disease in a Japanese population.
Neurosci Lett. 2009 Sep 18;461(2):177-80. Epub 2009 Jun 17.
Hata S, Fujishige S, Araki Y, Kato N, Araseki M, Nishimura M, Hartmann D, Saftig P, Fahrenholz F, Taniguchi M, Urakami K, Akatsu H, Martins RN, Yamamoto K, Maeda M, Yamamoto T, Nakaya T, Gandy S, Suzuki T.
Alcadein cleavages by APP {alpha}-and {gamma}-secretases generate small peptides p3-Alcs indicating Alzheimer disease-related {gamma}-secretase dysfunction.
J Biol Chem. 2009 Oct 28.
堀 映
脊髄発育異常の病理学: 1. 神経管形成異常
脊椎脊髄ジャーナル 22(6) 727-732 2009
堀 映
脊髄発育異常の病理学: 2. 終室と終室嚢胞および仙尾部皮下上衣腫
脊椎脊髄ジャーナル 22(7) 817-820 2009
堀 映
脊髄発育異常の病理学: 3. 終糸と脊髄係留症候群、および脊髄の発育と加齢
脊椎脊髄ジャーナル 22(8) 905-911 2009
堀 映
脊髄発育異常の病理学: 4. 人尾と偽尾
脊椎脊髄ジャーナル 22(9) 999-1001 2009
堀 映,赤津 裕康
脊髄発育異常の病理学: 5. 脊髄神経根の走行異常
脊椎脊髄ジャーナル 22(10) 1095-1101 2009
堀 映
脊髄発育異常の病理学: 6. 脊髄神経路(索)の走行異常ならびに脊髄の縦溝について
脊椎脊髄ジャーナル 22(11) 1189-1196 2009
堀 映
脊髄発育異常の病理学: 7. 仙部無形成
脊椎脊髄ジャーナル 22(12) 1265-1268 2009
Bernasconi R, Galli C, Calanca V, Nakajima T, Molinari M.
Stringent requirement for HRD1, SEL1L, and OS-9/XTP3-B for disposal of ERAD-LS substrates.
J Cell Biol. 2010 Jan 25;188(2):223-35.
堀 映
脊髄発育異常の病理学: 8 脊髄神経根内の異所性神経細胞と脊髄内異所性灰白質
脊椎脊髄ジャーナル 23(1) 7-13 2010
堀 映
脊髄発育異常の病理学: 9 脊髄正中離開
脊椎脊髄ジャーナル 23(2) 89-93 2010
堀 映
松村 明： 脊髄発育異常の病理学: 10 部分重複脊髄
脊椎脊髄ジャーナル 23(3) 165-171 2010
堀 映
脊髄発育異常の病理学: 11 重合体の重複脊髄と単体脊髄における脊髄半側低形成
脊椎脊髄ジャーナル 23(５) 487-491 2010